Skip to content
Home/Companies/Biotech/Cellino Biotech
Cellino Biotech

Cellino Biotech

Biotech·US·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Cellino Biotech?

Cellino Biotech is currently owned by Leaps by Bayer through Leaps by Bayer (2015 vintage), since 2022.

Hand-verified · updated 2026-07-03

Leaps by Bayer
Investor
Leaps by Bayer
Leaps by Bayer · 2015 · Evergreen

Key facts

HQUnited States
SectorBiotech
StatusActive
Websitecellinobio.com

More from Leaps by Bayer

Other portfolio companies in the same fund.

Celea Therapeutics
Celea Therapeutics
Active
BiotechUS· 2026
Leaf Agriculture
Active
ClimateTechUS· 2026
Sabanto
Active
AgTechUS· 2026
SonoThera
SonoThera
Active
BiotechUS· 2026
Souffle Therapeutics
Active
BiotechUS· 2025
WellTheory
WellTheory
Active
HealthTechUS· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Advanced Cell Diagnostics
Active
Summit PartnersUS
Aldevron
Aldevron
Active
TA AssociatesUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Clontech Laboratories
Active
Summit PartnersUS
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Track Cellino Biotech

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Cellino Biotech?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Cellino Biotech.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue